Jingsheng Wang

Papers

1

Total Citations

7

H-Index

1

About

Dr. Jingsheng Wang is a leading figure in radiation oncology, with a focused expertise in the management of spinal metastases through advanced stereotactic techniques. His major contributions center on the safety and efficacy of robotic stereotactic body radiotherapy (SBRT) for both primary treatment and reirradiation of spinal tumors. In his seminal 2014 work, "Robotic stereotactic irradiation and reirradiation for spinal metastases: safety and efficacy assessment," Dr. Wang addressed a critical clinical challenge: delivering high-dose, ablative radiation while sparing the radiosensitive spinal cord. This study, which has garnered 7 citations, provided foundational evidence that robotic SBRT offers a precise, non-invasive alternative to conventional radiotherapy, achieving effective tumor control with an acceptable toxicity profile, even in previously irradiated fields. His research has directly influenced clinical protocols, enabling safer reirradiation for patients with recurrent disease. By demonstrating that large fraction doses can be delivered with sub-millimeter accuracy, Dr. Wang has helped expand therapeutic options for patients with spinal metastases, improving both pain control and local tumor control. His work remains a cornerstone for clinicians seeking to balance aggressive treatment with spinal cord protection.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robotic stereotactic irradiation and reirradiation for spinal metastases: safety and efficacy assessment
7 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 7

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago